secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2023-04-07T23:59:59+00:00
Accession:  0001104659-23-042859
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharmaceuticals receives Nasdaq bid price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- Nasdaq letter dated April 5, 2023: ADS bid price below $1.00 for 30 consecutive business days.
- Company has until October 2, 2023 to regain compliance via closing bid >= $1.00 for 10 consecutive days.
- If not compliant by Oct 2, company may request additional 180-day grace period if meeting other listing standards.
- No immediate effect on Nasdaq listing; company is working on cure but cannot assure compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465923042859/0001104659-23-042859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465923042859/tm2312054d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-042859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer